PE
GSK icon

PCM Encore’s GSK GSK Stock Holding History

PCM Encore’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
11,500
+19
+0.2% +$1K 0.11% 176
2026
Q1 		$634K Buy
11,481
+699
+6% +$37.9K 0.13% 158
2025
Q4 		$529K Buy
+10,782
New +$503K 0.11% 185

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PCM Encore's GSK Position: Q2 2026 in Review

PCM Encore increased its GSK (GSK) stake by 0.17% in Q2 2026, buying an estimated $1K and bringing the position to 11,500 shares worth $603K. The position accounts for 0.11% of the portfolio, ranked #176.

PCM Encore first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $634K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • PCM Encore held 11,500 shares of GSK worth $603K as of Q2 2026.
  • PCM Encore bought 19 GSK shares in Q2 2026, an estimated $1K.
  • GSK made up 0.11% of PCM Encore's portfolio in Q2 2026, its #176 holding.
  • PCM Encore first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • PCM Encore's GSK position peaked at $634K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.